Poractant alfa

猪肺磷脂

Report date: 2025/07/15 17:47:14

Base Information

Drug NamePoractant alfa
Drug Alias NamePorcine lung surfactantCurasurfCurosurf固尔苏
ClassificationNatural product/Extract > Animal extract
Mechanisms of ActionCell membrane permeability enhancers
TargetsNot applicable
Therapy Area/IndicationsHypoplastic Left Heart SyndromeHeart Defects, CongenitalRespiratory Distress Syndrome, Newborn +[5] 
Global Approved IndicationsRespiratory Distress Syndrome, Newborn
Approved Indications in ChinaRespiratory Distress Syndrome, Newborn
Original Approved Country/TerritoryItaly
Original Approved Date1992/09/30
Country/TerritoryUnited StatesItalyUnited Kingdom +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesChiesi Farmaceutici SPA
China Registration ClassN/A

Develop Information

Active CompaniesChiesi Usa IncChiesi Farmaceutici SPA
Inactive CompaniesAzienda Ospedaliera Universitaria Integrata VeronaUniversity Of Michigan
Active IndicationsRespiratory Distress Syndrome, Newborn
Inactive IndicationsHypoplastic Left Heart SyndromeHeart Defects, CongenitalRespiratory Distress Syndrome, Adult +[4] 

Other Information

ATC CodeR07AA02
Related LinksWikipediaDrugBankKEGG